Treatment of long, diffuse in-stent restenosis with sirolimus-eluting stents

Steven Siu-Lung Li1, Y C So, C H Wong

  • 1Division of Cardiology, Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong. listevensl@yahoo.com

Insights

Treating long, diffuse in-stent restenosis is challenging. Multiple sirolimus-eluting stents successfully treated a patient with this condition, showing good long-term patency and no major adverse events.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • In-stent restenosis (ISR) poses a significant challenge in coronary artery interventions.
  • Long and diffuse ISR lesions are particularly difficult to treat effectively with current strategies.

Observation:

  • This case report details the management of a patient with a long, diffuse in-stent restenotic lesion.
  • The lesion required treatment with multiple sirolimus-eluting stents (SES) placed sequentially.

Findings:

  • Successful implantation of three 33-mm sirolimus-eluting stents resulted in widely patent vessels.
  • At six-month follow-up angiography, only 19% restenosis was observed in the most affected segment.
  • No major adverse cardiovascular events, including stent thrombosis, occurred within the ten-month follow-up period.

Implications:

  • The use of multiple SES may be a viable therapeutic option for complex, long, diffuse ISR.
  • This approach demonstrates potential for achieving favorable long-term outcomes in challenging ISR cases.
  • Further studies are warranted to validate this strategy in a larger patient cohort.